Swiss medical authorities have approved the first drug suitable to treat malaria in babies and very young children. Eight African countries that participated in clinical trials are now poised to ...
An international team of researchers has uncovered evidence of partial resistance to artemisinin derivatives -- the primary treatment for malaria -- in young children with severe malaria. Indiana ...
The first-ever treatment for malaria in young babies and infants has been approved. On Tuesday, Novartis announced it had received approval for the treatment, Coartem Baby (known as Riamet Baby in ...
For the first time in history, newborns and very young infants have access to a malaria treatment tailored to their unique needs. On July 8, Swissmedic – Switzerland’s regulatory agency – greenlit ...
Fortunate Mokoena receives funding from the Science for Africa Foundation (SFA) as part of the second Grand Challenges Africa grantees cohort by the Bill and Melinda Gates Foundation ...
A child is vaccinated against malaria on September 13, 2019 in Ndhiwa, Homabaya County, Western Kenya during the launch of a malaria vaccine in Kenya. The vaccine (Mosquirix) is the world's first ...
Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers from Children's Hospital of Philadelphia (CHOP) discovered a key process ...
NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Switzerland-based Novartis ...
Nigeria has joined seven other African nations in achieving a medical breakthrough with the approval of the first-ever malaria treatment for newborns and infants weighing less than five kilograms. The ...
Advances in vaccine technology, antibody therapies, and genetic surveillance are giving researchers new tools to fight ...
Researchers have shown that the evolution of a family of exported proteins in the malaria-causing parasite Plasmodium falciparum enabled it to infect humans. Researchers from the Francis Crick ...